Full Breakdown
Ken Paxton Intervenes in Ivermectin Case Involving Houston Doctor
2/14/2026, 4:31:34 AM
Overview of the Dispute
Texas Attorney General Ken Paxton has intervened in a legal dispute involving Dr. Mary Talley Bowden, a Houston physician reprimanded by the Texas Medical Board for prescribing ivermectin to a COVID-19 patient at Texas Health Huguley Hospital in 2021. The medical board accused Bowden of unprofessional conduct, asserting that she treated a patient without hospital privileges. Bowden has since filed a lawsuit to overturn the reprimand, and Paxton's intervention aims to support her case against the board.
Background of the Case
The controversy began when Bowden prescribed ivermectin to Jason Jones, a Tarrant County sheriff’s deputy hospitalized with COVID-19. Despite a court initially siding with Jones’ wife to allow Bowden to treat him, the hospital appealed the ruling. Bowden's nurse attempted to administer the drug, leading to police involvement when hospital staff intervened. Jones ultimately died in April 2023, though the cause of death was not disclosed.
Paxton's Position and Political Implications
Paxton has publicly criticized the Texas Medical Board for its actions against Bowden, claiming that the board acted without consulting medical experts. He described Bowden as a "champion for health freedom" and emphasized his commitment to protecting the rights of licensed professionals in Texas. Political analysts suggest that Paxton's support for Bowden, a figure associated with the anti-vaccine movement, may bolster his appeal in the upcoming GOP primary against incumbent Senator John Cornyn.
The Role of Ivermectin in the Medical Freedom Movement
Ivermectin has emerged as a controversial treatment within the context of the COVID-19 pandemic, particularly among those skeptical of vaccines. The drug, which is commonly used as a dewormer for livestock, has been made available over-the-counter in Texas, reflecting the influence of anti-vaccine activists. While some initial studies indicated potential antiviral effects in laboratory settings, major health organizations, including the World Health Organization and the American Medical Association, have advised against its use for COVID-19 outside clinical trials.
Official Statements & Responses
In a statement, Paxton asserted, “I will not stand by as Dr. Bowden has her Constitutional rights trampled and ability to serve her patients impeded with an illegal reprimand.” Bowden expressed gratitude for Paxton's support, stating, “It’s been a four and a half year fight... I hope we can put this matter to rest.” The Texas Medical Board has not commented on the ongoing litigation.
Criticism & Opposition
Critics of ivermectin's use for COVID-19 treatment highlight the lack of scientific support for its efficacy in humans. Major health authorities have consistently recommended against its use, emphasizing that the drug is not effective for treating the virus. This stance contrasts with the views of Bowden and her supporters, who argue for medical freedom and the right to prescribe treatments they believe are beneficial.
Conflicting Reports & Gaps
While Paxton's intervention signals a strong political stance, the Texas Medical Board's rationale for reprimanding Bowden remains unaddressed in detail. Additionally, discrepancies exist regarding the effectiveness of ivermectin, with some studies suggesting limited efficacy, while proponents continue to advocate for its use based on anecdotal evidence.
What's Next
As the legal battle unfolds, the implications of Paxton's intervention may influence both public perception and the political landscape in Texas, particularly as the state approaches primary elections. The outcome of Bowden's lawsuit against the Texas Medical Board could set a precedent for similar cases involving medical professionals and their treatment choices.
